Sheldon Rowan
- Oncology top 2%
- Cancer-related Molecular Pathways 5
- Molecular Biology top 2%
- Connexins and lens biology 13
- Gut microbiota and health 8
- Retinal Development and Disorders 8
- Developmental Biology and Gene Regulation 5
- Ophthalmology top 2%
- Retinal Diseases and Treatments 7
- Biotechnology top 2%
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research 11
-
- Aldose Reductase and Taurine 4
- Co-authors
- Constance L. CepkoMoshe OrenYgal HauptAllen TaylorKaren H. VousdenEitan ShaulianDavid E. FisherEloy Bejarano
- Journals
- Developmental Biology (8 papers)Investigative Ophthalmology & Visual Science (5 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesSpainIsrael
In The Last Decade
Sheldon Rowan
56 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 118
- Oncology 1.2k
- Molecular Biology 2.7k
- Ophthalmology 351
- Biotechnology 300
- Clinical Biochemistry 215
Countries citing papers authored by Sheldon Rowan
This map shows the geographic impact of Sheldon Rowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Rowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Rowan more than expected).
Fields of papers citing papers by Sheldon Rowan
This network shows the impact of papers produced by Sheldon Rowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Rowan. The network helps show where Sheldon Rowan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheldon Rowan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 16 | |
| 5 | Manipulation of Gut Microbiota Affects Diet- and Age-Related Retinal Degeneration | 2021 | 3 |
| 6 | 2021 | 66 | |
| 7 | 2019 | 20 | |
| 8 | 2018 | 161 | |
| 9 | 2018 | 60 | |
| 10 | Interaction of Metabolome and Microbiome Contributes to Dietary Glycemia-induced Age-related Macular Degeneration in Aged C57BL/6J Mice | 2016 | 1 |
| 11 | 2015 | 10 | |
| 12 | 2014 | 16 | |
| 13 | 2010 | 85 | |
| 14 | 2008 | 92 | |
| 15 | 2007 | 42 | |
| 16 | 2006 | 57 | |
| 17 | 2006 | 38 | |
| 18 | 2005 | 33 | |
| 19 | 2004 | 6 | |
| 20 | p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. | 1995 | 118 |
About Sheldon Rowan
Sheldon Rowan is a scholar working on Clinical Biochemistry, Ophthalmology and Periodontics, having authored 57 papers that have together received 3.6k indexed citations. Recurring topics across this work include Connexins and lens biology (13 papers), Advanced Glycation End Products research (11 papers), Gut microbiota and health (8 papers), Retinal Development and Disorders (8 papers), Retinal Diseases and Treatments (7 papers), Cancer-related Molecular Pathways (5 papers), Developmental Biology and Gene Regulation (5 papers) and Aldose Reductase and Taurine (4 papers). The work is most often cited by research in Oncology (1.2k citations), Molecular Biology (2.7k citations) and Ophthalmology (351 citations). Sheldon Rowan has collaborated with scholars based in United States, Spain and Israel. Frequent co-authors include Constance L. Cepko, Moshe Oren, Ygal Haupt, Allen Taylor, Karen H. Vousden, Eitan Shaulian, David E. Fisher, Eloy Bejarano, Yaacov Ben‐David and Maria Rosa Bani. Their work appears in journals such as Developmental Biology, Investigative Ophthalmology & Visual Science, Proceedings of the National Academy of Sciences, Advances in experimental medicine and biology and Experimental Eye Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.